Quarterly Results

  • Company Name :
Aurobindo Pharma Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 524804
  • NSE Symbol:
  • AUROPHARMA
  • P/E(TTM):
  • 30.27
  • ISIN Demat:
  • INE406A01037
  • Div & Yield%:
  • -
  • EPS(TTM):
  • 33.74
  • Book Value(₹):
  • 350.46
  • Market Cap(₹Cr.):
  • 59,847.77
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars June 2025 ( Cr)March 2025 ( Cr)December 2024 ( Cr)
Gross Sales 2,822.14 2,721.43 2,883.56
Excise Duty 0.00 0.00 0.00
Net Sales 2,822.14 2,721.43 2,883.56
Other Operating Income 26.03 10.56 33.07
Other Income 83.77 113.98 54.26
Total Income 2,931.94 2,845.97 2,970.89
Total Expenditure 2,051.83 2,135.48 2,203.48
PBIDT 880.11 710.49 767.41
Interest 60.00 61.09 66.19
PBDT 820.11 649.40 701.22
Depreciation 70.02 93.88 68.28
Tax 187.68 155.25 164.03
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 3.28 -7.90 -3.14
Reported Profit After Tax 559.13 408.17 472.05
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 559.13 408.17 472.05
EPS (Unit Curr.) 9.63 7.03 8.13
EPS (Adj) (Unit Curr.) 9.63 7.03 8.13
Calculated EPS (Unit Curr.) 9.63 7.03 8.13
Calculated EPS (Adj) (Unit Curr.) 9.63 7.03 8.13
Calculated EPS (Ann.) (Unit Curr.) 38.51 28.11 32.51
Calculated EPS (Adj) (Ann.) (Unit Curr.) 38.51 28.11 32.51
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 58.08 58.08 58.08
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 31.19 26.11 26.61
PBDTM(%) 29.06 23.86 24.32
PATM(%) 19.81 15.00 16.37